{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:08:08Z","timestamp":1794701288302,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T00:00:00Z","timestamp":1563408000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T00:00:00Z","timestamp":1563408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","award":["84000791"],"award-info":[{"award-number":["84000791"]}],"id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1038\/s41433-019-0534-8","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T12:02:47Z","timestamp":1563451367000},"page":"491-498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Intravitreal dexamethasone implant as an alternative to systemic steroids as prophylaxis for uveitic cataract surgery: a randomized trial"],"prefix":"10.1038","volume":"34","author":[{"given":"Aditya","family":"Sudhalkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay","family":"Vasavada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Bhojwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viraj","family":"Vasavada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shail","family":"Vasavada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Vasavada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaresh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,18]]},"reference":[{"key":"534_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/ICU.0b013e32831b9b22","volume":"20","author":"R Van Gelder","year":"2009","unstructured":"Van Gelder R, Leveque T. Cataract surgery in the setting of uveitis. Curr Opin Ophthalmol. 2009;20:42\u20135.","journal-title":"Curr Opin Ophthalmol"},{"key":"534_CR2","first-page":"472","volume":"31","author":"S Androudi","year":"2005","unstructured":"Androudi S, Ahmed M, Fiore T, et al. Combined pars plana vitrectomy and phacoemulsification to restore visual acuity in patients with chronic uveitis. JCRS. 2005;31:472\u20138.","journal-title":"JCRS"},{"key":"534_CR3","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/S0161-6420(93)31567-8","volume":"100","author":"S Malinowski","year":"1993","unstructured":"Malinowski S, Pulido J, Folk J. Long-term visual outcome and complications associated with pars planitis. Ophthalmology. 1993;100:818\u201325.","journal-title":"Ophthalmology"},{"key":"534_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00055735-200302000-00001","volume":"14","author":"CS Foster","year":"2003","unstructured":"Foster CS, Rashid S. Management of coincident cataract and uveitis. Curr Opin Ophthalmol. 2003;14:1\u20136.","journal-title":"Curr Opin Ophthalmol"},{"key":"534_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/548453","volume":"2012","author":"Rupesh Agrawal","year":"2012","unstructured":"Agrawal R, Murthy S, Ganesh S, et al. Cataract surgery in uveitis. Int J Inflamm. 2012;2012:548453. \nhttps:\/\/doi.org\/10.1155\/2012\/548453\n\n.","journal-title":"International Journal of Inflammation"},{"key":"534_CR6","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jcrs.2010.02.019","volume":"36","author":"J Ram","year":"2010","unstructured":"Ram J, Gupta A, Kumar S, et al. Phacoemulsification with intraocular lens implantation in patients with uveitis. J Cataract Refract Surg. 2010;36:1283\u20138.","journal-title":"J Cataract Refract Surg"},{"key":"534_CR7","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/j.jcrs.2004.02.090","volume":"30","author":"SK Ganesh","year":"2004","unstructured":"Ganesh SK, Babu K, Biswas J. Phacoemulsification with intraocular lens implantation in cases of pars planitis. J Cataract Refract Surg. 2004;30:2072\u20136.","journal-title":"J Cataract Refract Surg"},{"key":"534_CR8","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jcrs.2013.09.013","volume":"40","author":"PJ Tomlins","year":"2014","unstructured":"Tomlins PJ, Sivaraj RR, Rauz S, et al. Long-term biocompatibility and visual outcomes of a hydrophilic acrylic intraocular lens in patients with uveitis. J Cataract Refract Surg. 2014;40:618\u201325.","journal-title":"J Cataract Refract Surg"},{"key":"534_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ajo.2009.02.029","volume":"148","author":"M-L Belair","year":"2009","unstructured":"Belair M-L, Kim SJ, Thorne JE, et al. Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography. Am J Ophthalmol. 2009;148:128\u201335.e2.","journal-title":"Am J Ophthalmol"},{"key":"534_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","volume":"130","author":"DA Jabs","year":"2000","unstructured":"Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492\u2013513.","journal-title":"Am J Ophthalmol"},{"key":"534_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","volume":"92","author":"RB Nussenblatt","year":"1985","unstructured":"Nussenblatt RB, Palestine AG, Chan CC, et al. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92:467\u201371.","journal-title":"Ophthalmology"},{"key":"534_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/09273940500545684","volume":"14","author":"B van Kooij","year":"2006","unstructured":"van Kooij B, Rothova A, de Vries P. The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema. Ocul Immunol Inflamm. 2006;14:73\u201385.","journal-title":"Ocul Immunol Inflamm"},{"key":"534_CR13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.ajo.2009.11.019","volume":"149","author":"The Multicenter Uveitis Steroid Treatment Trial Research Group.","year":"2010","unstructured":"The Multicenter Uveitis Steroid Treatment Trial Research Group. The multicenter uveitis steroid treatment (MUST) trial: rationale, design and baseline characteristics. Am J Ophthalmol. 2010;149:550\u201361e10.","journal-title":"Am J Ophthalmol"},{"key":"534_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nyas.12824","volume":"1358","author":"SM Whitcup","year":"2015","unstructured":"Whitcup SM, Robinson MR. Development of a dexamethasone intravitreal implant for the treatment of noninfectious posterior segment uveitis. Ann N Y Acad Sci. 2015;1358:1\u201312.","journal-title":"Ann N Y Acad Sci."},{"key":"534_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1001\/archopht.125.3.309","volume":"125","author":"BD Kupperman","year":"2007","unstructured":"Kupperman BD, Blumenkranz MS, Haller JA, et al. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol. 2007;125:309\u201317.","journal-title":"Arch Ophthalmol"},{"key":"534_CR16","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.ajo.2008.12.033","volume":"147","author":"GA Williams","year":"2009","unstructured":"Williams GA, Haller JA, Kupperman BD, et al. Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or irvine-gass syndrome. Am J Ophthalmol. 2009;147:1048\u20131054.","journal-title":"Am J Ophthalmol"},{"key":"534_CR17","doi-asserted-by":"publisher","first-page":"767","DOI":"10.4103\/0301-4738.171505","volume":"63","author":"S Palla","year":"2015","unstructured":"Palla S, Biswas J, Nagesha CK. Efficacy of Ozurdex implant in treatment of noninfectious intermediate uveitis. Indian J Ophthalmol. 2015;63:767\u20137.","journal-title":"Indian J Ophthalmol"},{"key":"534_CR18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3109\/09273948.2013.822087","volume":"21","author":"A Gupta","year":"2013","unstructured":"Gupta A, Ram J, Gupta A, Gupta V. Intraoperative dexamethasone implant in uveitis patients with cataract undergoing phacoemulsification. Ocul Immunol Inflamm. 2013;21:462\u20137.","journal-title":"Ocul Immunol Inflamm"},{"key":"534_CR19","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jaapos.2013.07.014","volume":"17","author":"M Cordero-Coma","year":"2013","unstructured":"Cordero-Coma M, Garzo I, Calleja S, et al. Preoperative cataract surgery use of an intravitreal dexamethasone implant (Ozurdex) in a patient with juvenile idiopathic arthritis and chronic anterior uveitis. J AAPOS. 2013;17:632\u20134.","journal-title":"J AAPOS"},{"key":"534_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40123-016-0052-8","volume":"5","author":"FJ Go\u00f1i","year":"2016","unstructured":"Go\u00f1i FJ, Stalmans I, Denis P, et al. Elevated intraocular pressure after intravitreal steroid injection in diabetic macular edema: monitoring and management. Ophthalmol Ther. 2016;5:47\u201361.","journal-title":"Ophthalmol Ther."},{"key":"534_CR21","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.ophtha.2010.03.032","volume":"117","author":"JA Haller","year":"2010","unstructured":"Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010;117:1134\u2013.e3.","journal-title":"Ophthalmology"},{"key":"534_CR22","unstructured":"National Collaborating Centre for Acute Care. Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension. NICE clinical guidelines, no. 85. London: National Collaborating Centre for Acute Care (UK); 2009."},{"key":"534_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509\u201316.","journal-title":"Am J Ophthalmol"},{"key":"534_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4103\/tjo.tjo_62_17","volume":"8","author":"M Nagpal","year":"2018","unstructured":"Nagpal M, Mehrotra N, Juneja R, Jain H. Dexamethasone implant (0.7 mg) in Indian patients with macular edema: real-life scenario. Taiwan J Ophthalmol. 2018;8:141\u20138.","journal-title":"Taiwan J Ophthalmol"},{"key":"534_CR25","doi-asserted-by":"publisher","first-page":"767","DOI":"10.4103\/0301-4738.171505","volume":"63","author":"S Palla","year":"2015","unstructured":"Palla S, Biswas J, Nagesha CK. Efficacy of Ozurdex implant in treatment of non-infectious intermediate uveitis. Indian J Ophthalmol. 2015;63:767\u201370.","journal-title":"Indian J Ophthalmol"},{"key":"534_CR26","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/eye.2015.246","volume":"30","author":"J Chabblani","year":"2016","unstructured":"Chabblani J, Bansal P, Veritti D, et al. Dexamethasone implant in diabetic macular edema in real-life situations. Eye (Lond). 2016;30:426\u201330.","journal-title":"Eye (Lond)"},{"key":"534_CR27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","volume":"129","author":"C Lowder","year":"2011","unstructured":"Lowder C, Belfort R Jr, Lightman S, et al. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol. 2011;129:545\u201353.","journal-title":"Arch Ophthalmol"},{"key":"534_CR28","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.jcrs.2006.04.018","volume":"32","author":"J Li","year":"2006","unstructured":"Li J, Heinz C, Zurek-Imhoff B, et al. Intraoperative intraocular triamcinolone injection prophylaxis for post-cataract surgery fibrin formation in uveitis associated with juvenile idiopathic arthritis. J Cataract Refract Surg. 2006;32:1535\u20139.","journal-title":"J Cataract Refract Surg"},{"key":"534_CR29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3109\/09273948.2010.486098","volume":"18","author":"AA Alkawas","year":"2010","unstructured":"Alkawas AA, Hamdy AM, Shahien EA. Intraoperative intravitreal injection of triamcinolone acetonide for cataract extraction in patients with uveitis. Ocul Immunol Inflamm. 2010;18:402\u20137.","journal-title":"Ocul Immunol Inflamm"},{"key":"534_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ajo.2016.03.049","volume":"166","author":"MB Larochelle","year":"2016","unstructured":"Larochelle MB, Smith J, Dacey MS. Dexamethasone intravitreal implant in the treatment of uveitic macular edema in the perioperative cataract setting: a case series. Am J Ophthalmol. 2016;166:149\u2013153.","journal-title":"Am J Ophthalmol"},{"key":"534_CR31","unstructured":"American academy of ophthalmology preferred practice patterns: uveitis and cataract surgery. \nhttps:\/\/www.aao.org\/clinical-questions\/uveitis-cataract-surgery\n\n. Accessed 4 Oct 2017."},{"key":"534_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.sjopt.2011.10.003","volume":"26","author":"U Baheti","year":"2012","unstructured":"Baheti U, Siddique S, Foster S. Cataract surgery in patients with history of uveitis. Saudi J Ophthalmol. 2012;26:55\u201360.","journal-title":"Saudi J Ophthalmol"},{"key":"534_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/sj.eye.6701450","volume":"19","author":"I Rahman","year":"2005","unstructured":"Rahman I, Jones N. Long-term results of cataract extraction with intraocular lens implantation in patients with uveitis. Eye (Lond). 2005;19:191\u20137.","journal-title":"Eye (Lond)"},{"key":"534_CR34","first-page":"1","volume":"21","author":"G Gupta","year":"2018","unstructured":"Gupta G, Ram J, Gupta V, Singh R, Bansal R, Chawla-Gupta P, et al. Efficacy of Intravitreal dexamethasone implant in patients of uveitis undergoing cataract surgery. Ocul Immunol Inflamm. 2018;21:1\u20139.","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0534-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0534-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0534-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:07:56Z","timestamp":1684616876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-019-0534-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,18]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["534"],"URL":"https:\/\/doi.org\/10.1038\/s41433-019-0534-8","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,18]]},"assertion":[{"value":"2 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}